E0 ConsensusWeak / uncertainPEM unclearSystematic-ReviewPeer-reviewedReviewed
A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt, Matthew, Campagnolo, N, Staines, D et al. · Probiotics and antimicrobial proteins · 2018 · DOI
Quick Summary
This review looked at whether probiotics (beneficial bacteria) might help with stomach and bowel problems that many people with ME/CFS experience. Researchers searched medical databases and found 25 studies on this topic. While probiotics showed promise for irritable bowel syndrome in the general population, there wasn't enough good-quality research to say whether they actually help people with ME/CFS.
Why It Matters
Many people with ME/CFS suffer from gastrointestinal problems that significantly impact their quality of life. This review identifies a critical gap in research—while probiotics show benefits for similar bowel conditions in other populations, we don't yet have solid evidence they work for ME/CFS patients. Understanding this distinction helps guide both clinical decisions and future research priorities.
Observed Findings
- Of 3,381 publications identified, only 25 met inclusion criteria for systematic review
- Most included studies (n=24) were randomized controlled trials
- Evidence quality for probiotics in IBS was rated as excellent
- Evidence quality for probiotics in CFS/ME was rated as poor and limited
- Studies examined diverse outcomes including bowel symptoms, quality of life, and psychological symptoms
Inferred Conclusions
- Insufficient evidence currently exists to recommend probiotic interventions for CFS/ME patients despite potential benefits in IBS
- The poor quality and limited number of CFS/ME-specific probiotic studies represents a significant research gap
- Standardization of study protocols and methodology is essential for future CFS/ME probiotic research
- A clear distinction exists between evidence strength for probiotics in IBS versus CFS/ME populations
Remaining Questions
- What specific probiotic strains or combinations might be beneficial for ME/CFS gastrointestinal symptoms?
- Why do probiotics appear effective in IBS but lack evidence in CFS/ME—are the conditions mechanistically different?
What This Study Does Not Prove
This review does not prove that probiotics are ineffective in ME/CFS—only that there isn't enough high-quality evidence yet to make that determination. The poor quality of existing CFS/ME probiotic studies may reflect research limitations rather than treatment ineffectiveness. The review also cannot explain why probiotics work for IBS but may differ in ME/CFS populations.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionMixed CohortPEM Not Defined
Metadata
- DOI
- 10.1007/s12602-018-9397-8
- PMID
- 29464501
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.